Dry eye/OSD

Not All DED Patients Have Chronic Symptoms

By Richard A. Adler, MD, FACS; and Nathan M. Radcliffe, MD Specialists now have a topical medication specifically approved for the short-term (up to 2 weeks) treatment of the signs and symptoms of dry eye disease (DED). With the availability of Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%; Kala Pharmaceuticals), we...

Read More